Sep 2026
Targeting KRAS reprograms a Treg-dominant immunosuppressive microenvironment and sensitizes KRAS-mutant gastric adenocarcinoma to CTLA-4 immunotherapy.
Findings identify oncogenic KRAS as a key regulator of TGF-β-dependent immune suppression in GA and provide mechanistic insight into immune evasion within this molecular subtype.
Xiao-Huan Tang, Pei-Yao Yang, Xiao-Yong Guo et al.
· Science China Life Sciences · 0 citations